CRYO-CELL INTERNATIONAL, INC. Increase Decrease In Operating Lease Liability
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Increase Decrease In Operating Lease Liability of -$222.30 thousand for the 6-month period ending 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-15
- CRYO-CELL INTERNATIONAL, INC. increase decrease in operating lease liability for the quarter ending 2026-05-31 was -$112.64K.
- CRYO-CELL INTERNATIONAL, INC. increase decrease in operating lease liability for the quarter ending 2026-02-28 was -$109.65K.
- CRYO-CELL INTERNATIONAL, INC. increase decrease in operating lease liability for the quarter ending 2025-11-30 was -$106.96K.
- CRYO-CELL INTERNATIONAL, INC. increase decrease in operating lease liability for the quarter ending 2025-08-31 was -$114.73K.
- CRYO-CELL INTERNATIONAL, INC. increase decrease in operating lease liability for fiscal 2025 was -$424.70K.
- CRYO-CELL INTERNATIONAL, INC. increase decrease in operating lease liability for fiscal 2024 was -$245.17K.
- CRYO-CELL INTERNATIONAL, INC. increase decrease in operating lease liability for fiscal 2023 was -$271.23K.
- CRYO-CELL INTERNATIONAL, INC. increase decrease in operating lease liability for fiscal 2022 was -$312.07K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-05-31 | -$112.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | -$222.30K 10-Q · filed 2026-07-15 | -$329.25K derived: sum of 3 quarters · filed 2026-07-15 | -$443.98K derived: sum of 4 quarters · filed 2026-07-15 |
| 2026-02-28 | -$109.65K 10-Q · filed 2026-04-14 | -$216.61K derived: sum of 2 quarters · filed 2026-04-14 | -$331.34K derived: sum of 3 quarters · filed 2026-04-14 | -$439.79K derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-11-30 | -$106.96K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$221.69K derived: sum of 2 quarters · filed 2026-02-27 | -$330.14K derived: sum of 3 quarters · filed 2026-07-15 | -$424.70K 10-K · filed 2026-02-27 |
| 2025-08-31 | -$114.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | -$223.18K derived: sum of 2 quarters · filed 2026-07-15 | -$317.74K 10-Q · filed 2025-10-15 | -$387.28K derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-05-31 | -$108.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-15 | -$203.02K 10-Q · filed 2026-07-15 | -$272.55K derived: sum of 3 quarters · filed 2026-07-15 | -$337.68K derived: sum of 4 quarters · filed 2026-07-15 |
| 2025-02-28 | -$94.56K 10-Q · filed 2026-04-14 | -$164.10K derived: sum of 2 quarters · filed 2026-04-14 | -$229.22K derived: sum of 3 quarters · filed 2026-04-14 | -$285.05K derived: sum of 4 quarters · filed 2026-04-14 |
| 2024-11-30 | -$69.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$134.66K derived: sum of 2 quarters · filed 2026-02-27 | -$190.49K derived: sum of 3 quarters · filed 2026-02-27 | -$245.17K 10-K · filed 2026-02-27 |
| 2024-08-31 | -$65.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | -$120.95K derived: sum of 2 quarters · filed 2025-10-15 | -$175.63K 10-Q · filed 2025-10-15 | -$229.19K derived: sum of 4 quarters · filed 2025-10-15 |
| 2024-05-31 | -$55.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-15 | -$110.51K 10-Q · filed 2025-07-15 | -$164.07K derived: sum of 3 quarters · filed 2025-07-15 | -$224.73K derived: sum of 4 quarters · filed 2025-07-15 |
| 2024-02-29 | -$54.68K 10-Q · filed 2025-04-14 | -$108.24K derived: sum of 2 quarters · filed 2025-04-14 | -$168.90K derived: sum of 3 quarters · filed 2025-04-14 | -$245.87K derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-11-30 | -$53.56K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$114.22K derived: sum of 2 quarters · filed 2025-02-28 | -$191.18K derived: sum of 3 quarters · filed 2025-02-28 | -$271.23K 10-K · filed 2025-02-28 |
| 2023-08-31 | -$60.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-15 | -$137.62K derived: sum of 2 quarters · filed 2024-10-15 | -$217.67K 10-Q · filed 2024-10-15 | -$297.03K derived: sum of 4 quarters · filed 2024-10-15 |
| 2023-05-31 | -$76.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-15 | -$157.01K 10-Q · filed 2024-07-15 | -$236.37K derived: sum of 3 quarters · filed 2024-07-15 | -$315.04K derived: sum of 4 quarters · filed 2024-07-15 |
| 2023-02-28 | -$80.05K 10-Q · filed 2024-04-15 | -$159.41K derived: sum of 2 quarters · filed 2024-04-15 | -$238.08K derived: sum of 3 quarters · filed 2024-04-15 | -$315.86K derived: sum of 4 quarters · filed 2024-04-15 |
| 2022-11-30 | -$79.36K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$158.03K derived: sum of 2 quarters · filed 2024-02-28 | -$235.81K derived: sum of 3 quarters · filed 2024-02-28 | -$312.07K 10-K · filed 2024-02-28 |
| 2022-08-31 | -$78.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-12 | -$156.45K derived: sum of 2 quarters · filed 2023-10-12 | -$232.71K 10-Q · filed 2023-10-12 | -$306.82K derived: sum of 4 quarters · filed 2023-10-12 |
| 2022-05-31 | -$77.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-14 | -$154.03K 10-Q · filed 2023-07-14 | -$228.14K derived: sum of 3 quarters · filed 2023-07-14 | -$301.61K derived: sum of 4 quarters · filed 2023-07-14 |
| 2022-02-28 | -$76.25K 10-Q · filed 2023-04-21 | -$150.36K derived: sum of 2 quarters · filed 2023-04-21 | -$223.83K derived: sum of 3 quarters · filed 2023-04-21 | -$291.59K derived: sum of 4 quarters · filed 2023-04-21 |
| 2021-11-30 | -$74.11K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$147.58K derived: sum of 2 quarters · filed 2023-02-28 | -$215.33K derived: sum of 3 quarters · filed 2023-02-28 | -$280.84K 10-K · filed 2023-02-28 |
| 2021-08-31 | -$73.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-18 | -$141.22K derived: sum of 2 quarters · filed 2022-10-18 | -$206.73K 10-Q · filed 2022-10-18 | -$273.36K derived: sum of 4 quarters · filed 2022-10-18 |
| 2021-05-31 | -$67.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-11 | -$133.26K 10-Q · filed 2022-07-11 | -$199.89K derived: sum of 3 quarters · filed 2022-07-11 | |
| 2021-02-28 | -$65.50K 10-Q · filed 2022-04-13 | -$132.14K derived: sum of 2 quarters · filed 2022-04-13 | ||
| 2020-11-30 | -$66.63K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$263.57K 10-K · filed 2022-02-22 | ||
| 2020-08-31 | -$196.94K 10-Q · filed 2021-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |